Abstract
As the world's population ages, Alzheimer's disease is currently the seventh most common
cause of death globally; the burden is anticipated to increase, especially among middle-class
and elderly persons. Artificial intelligence-based algorithms that work well in hospital environments
can be used to identify Alzheimer's disease. A number of databases were searched for English-
language articles published up until March 1, 2024, that examined the relationships between
artificial intelligence techniques, eye movements, and Alzheimer's disease. A novel non-invasive
method called eye movement analysis may be able to reflect cognitive processes and identify anomalies
in Alzheimer's disease. Artificial intelligence, particularly deep learning, and machine
learning, is required to enhance Alzheimer's disease detection using eye movement data. One sort
of deep learning technique that shows promise is convolutional neural networks, which need further
data for precise classification. Nonetheless, machine learning models showed a high degree of
accuracy in this context. Artificial intelligence-driven eye movement analysis holds promise for
enhancing clinical evaluations, enabling tailored treatment, and fostering the development of early
and precise Alzheimer's disease diagnosis. A combination of artificial intelligence-based systems
and eye movement analysis can provide a window for early and non-invasive diagnosis of
Alzheimer's disease. Despite ongoing difficulties with early Alzheimer's disease detection, this presents
a novel strategy that may have consequences for clinical evaluations and customized medication
to improve early and accurate diagnosis.
Keywords:
Eye movements, Alzheimer's disease, artificial intelligence, neurodegenerative disease, geriatrics, machine learning, deep learning.
[16]
Yousefi M, Maleki SF, Jafarizadeh A, Youshanlui MA, Jafari A, Pedrammehr S, et al. Advancements in radiomics and artificial intelligence for thyroid cancer diagnosis. arXiv preprint arXiv:240407239 2024.
[46]
Khaleel AH, Abbas TH, Ibrahim A-WS. Best low-cost methods for real-time detection of the eye and gaze tracking. i-com 2024; 23(1)
[51]
Bazargani YS, Mirzaei M, Sobhi N, Abdollahi M, Jafarizadeh A, Pedrammehr S, et al. Artificial intelligence and diabetes mellitus: An inside look through the retina. arXiv preprint arXiv:240218600 2024.
[52]
Das K, Behera RN. A survey on machine learning: Concept, algorithms and applications. IJIRCCE 2017; 5(2): 1301-9.
[53]
Jafarizadeh A, Maleki SF, Pouya P, Sobhi N, Abdollahi M, Pedrammehr S, et al. Current and future roles of artificial intelligence in retinopathy of prematurity. arXiv preprint arXiv:240209975 2024.
[59]
Barral O, Jang H, Newton-Mason S, Shajan S, Soroski T, Carenini G, et al. Non-invasive classification of Alzheimer’s disease using eye tracking and language. PMLR 2020; 126: 813-41.
[64]
Abdollahi M, Jafarizadeh A, Asbagh AG, Sobhi N, Pourmoghtader K, Pedrammehr S, et al. Artificial intelligence in assessing cardiovascular diseases and risk factors via retinal fundus images: A review of the last decade. arXiv preprint arXiv:231107609 2023.
[67]
Biondi J, Fernandez G, Castro S, Agamennoni O. Eye movement behavior identification for Alzheimer’s disease diagnosis. JIN 2018; 17(4): 349-54.
[69]
Zuo F, Jing P, Sun J, Ji Y, Liu Y. Deep learning-based eye-tracking analysis for diagnosis of alzheimer’s disease using 3d comprehensive visual stimuli. arXiv preprint arXiv:230306868 2023.
[80]
Lombardi A, Tavares JMR, Tangaro S. Explainable artificial intelligence (xai) in systems neuroscience. Front Syst Neurosci 2021; 2: 766980.
[81]
Božić V. Explainable artificial intelligence (XAI): Enhancing transparency and trust in AI systems. Preprint 2023.